Learn about our comprehensive antibody validation methods to ensure monospecificity.  Antibody Validation>>

Printable Datasheet

c-Myc Oncoprotein Antibody [9E10.3]

In Stock
Catalog Number Formulation Size Price
4609-MSM4-P0
Purified Ab with BSA and Azide at 200ug/ml
20ug
$229.00
4609-MSM4-P1
Purified Ab with BSA and Azide at 200ug/ml
100ug
$519.00
4609-MSM4-P1ABX
Purified Ab WITHOUT BSA and Azide at 1.0mg/ml
100ug
$519.00
Flat Rate Domestic: $60 | Orders outside the US - Contact Us for Order Information | Ships next business day
Formalin-fixed, paraffin-embedded human Cervical Carcinoma stained with c-Myc Mouse Monoclonal Antibody (9E10.3).

Formalin-fixed, paraffin-embedded human Cervical Carcinoma stained with c-Myc Mouse Monoclonal Antibody (9E10.3).

SDS-PAGE Analysis of Purified c-Myc Mouse Monoclonal Antibody (9E10.3). Confirmation of Integrity and Purity of Antibody

SDS-PAGE Analysis of Purified c-Myc Mouse Monoclonal Antibody (9E10.3). Confirmation of Integrity and Purity of Antibody

Applications & Dilutions

Applications Tested Dillution Protocol Note
Flow Cytometry (Flow)
1-2ug/million cells
Flow Cytometry Protocol
Immunofluorescence (IF)
1-3ug/ml
Immunohistochemistry (IHC)
1-2ug/ml
IHC Protocol
30 min at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes

Summary

It recognizes a transcription factor of 64-67kDa, identified as c-myc. Its epitope spans between aa 410-419 (EQKLISEEDL) which is a specific portion of an alpha helical region of human c-myc protein. This MAb shows no cross-reaction with v-myc. c-myc is involved in the control of cell proliferation and differentiation and is amplified and/or overexpressed in a variety of tumors. Over-expression of c-myc protein occurs frequently in luminal cells of prostate intraepithelial neoplasia as well as in most primary carcinomas and metastatic disease.

Product Properties & Targets

Antibody Type
Mouse Monoclonals
Host
Mouse
Applications
Flow Cytometry, Immunofluorescence, Immunohistochemistry
Species Reactivity
Human
Research Areas
Apoptosis, Autophagy, Breast Cancer, Cancer, Cardiovascular, Developmental Biology, Hypoxia, Immunology, Bladder Cancer, Colon Cancer, Cytokine Signaling, Infectious Disease, Lung Cancer, MAPK Signaling, Nuclear Marker, Signal Transduction, Stem Cell Differentiation, Transcription Factors
Isotype / Light Chain
IgG1 / Kappa
Cellular Localization
Nucleolus, Nucleoplasm, Nucleus
Gene Name
MYC
Positive Control
HL-60 cells. Cervical Carcinoma.
Immunogen
A synthetic peptide, corresponding to aa 408-439 (AEEQKLISEEDLLRKRREQLKHKLEQLRNSCA) from C-terminus of human c-myc, coupled to KLH.
Alternate Names
Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, Class E basic helix-loop-helix protein 39 (bHLHe39), MRTL, Myc2, Niard, Nird, Proto-oncogene c-Myc, RNCMYC, Transcription factor p64, Transcriptional regulator Myc-A, V-Myc avian myelocytomatosis viral oncogene homolog

Database Links

Entrez Gene ID
4609
SwissProt
P01106

Additional Information

Clone
9E10.3
Chromosome Location
8q24.21
Mol. Weight of Antigen
62-64kDa

Related Antibodies

View All MYC Antibodies

Functions

  • Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3' (PubMed:24940000, PubMed:25956029). Activates the transcription of growth-related genes (PubMed:24940000, PubMed:25956029). Binds to the VEGFA promoter, promoting VEGFA production and subsequent sprouting angiogenesis (PubMed:24940000, PubMed:25956029). Regulator of somatic reprogramming, controls self-renewal of embryonic stem cells (By similarity). Functions with TAF6L to activate target gene expression through RNA polymerase II pause release (By similarity). Positively regulates transcription of HNRNPA1, HNRNPA2 and PTBP1 which in turn regulate splicing of pyruvate kinase PKM by binding repressively to sequences flanking PKM exon 9, inhibiting exon 9 inclusion and resulting in exon 10 inclusion and production of the PKM M2 isoform (PubMed:20010808).

Key References

  • Evan GI, et. al. Molecular and Cellular Biology, 1985, 5(12):3610-6.

PubMed Links

Storage & Stability

Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

Limitations

This antibody is available for research use only and is not approved for use in diagnosis.

Supplied as

200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0mg/ml.

Warranty

There are no warranties, expressed or implied, which extend beyond this description. Company is not liable for any personal injury or economic loss resulting from this product.

Reviews

There are no reviews yet.

Be the first to review “c-Myc Oncoprotein Antibody”

Your email address will not be published. Required fields are marked *

PARTNERSHIP OPPORTUNITIES

We hold Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK
NeoBiotechnologies Logo
Company Info
Antibodies
Antibody Validation
Research Areas
Resources
Newsletter Signup Updates & Sales